BioSpace News Archive

Progressive familial intrahepatic cholestasis (PFIC) type 2 is a heterogeneous group of autosomal recessive disorder that occurs during childhood and disturbs the bile formation.

The platelet concentration systems market is expected to gain promising growth across the assessment period of 2020-2030.

Medical imaging in orthopedics helps physicians to non-invasively analyze the body’s internal anatomy to aid in diagnosing a medical condition.

Oral solid dosage pharmaceutical formulation refers to the primary process undertaken by various companies making drugs.

Lumbar disc replacement is a type of spine surgery that involves replacement of a damaged or degenerated disc of spine with an artificial lumbar disc replacement device in the lumbar region.

Rejuveron Life Sciences AG, a Zürich-based biotechnology company developing technologies for healthy aging, today announced that it has strengthened its support to a near-majority holding in Endogena Therapeutics Inc., an endogenous regenerative therapeutics company.

Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that the Compensation Committee of its Board of Directors granted equity awards under Altimmune’s 2018 Inducement Grant Plan, as a material inducement to employ Richard Eisenstadt as Altimmune’s Chief Financial Officer effective December 31, 2021.

Teleflex Incorporated (NYSE: TFX) today announced that the company has received reimbursement approval from the Central Social Insurance Medical Council of Japan (Chuikyo) of its UroLift System for patients who require treatment for benign prostatic hyperplasia (BPH).

GENETWORx announced today the launch of a program designed to add products, services and capacity to the GENETWORx portfolio of laboratory testing products, services, data, and technology.

Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis.